Franklin Resources
CLRB icon

Franklin Resources’s Cellectar Biosciences CLRB Stock Holding History

Franklin Resources’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-345
Closed -$17.7K – 2328
2022
Q4 		$17.7K Hold
345
– – ﹤0.01% 2280
2022
Q3 		$35K Hold
345
– – ﹤0.01% 2224
2022
Q2 		$42K Sell
345
-130
-27% -$18.6K ﹤0.01% 2260
2022
Q1 		$98K Hold
475
– – ﹤0.01% 2299
2021
Q4 		$95K Hold
475
– – ﹤0.01% 2349
2021
Q3 		$132K Buy
+475
New +$145K ﹤0.01% 2294

Other funds holding CLRB

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
1WM
1900 Wealth Management San Antonio, Texas $1.56B AUM 14.13% 1-Year Est. Return

Franklin Resources's CLRB Position: Q1 2023 in Review

Franklin Resources sold out of Cellectar Biosciences (CLRB) in Q1 2023, closing a stake of 345 shares — an estimated $17.7K sold.

Franklin Resources first reported a position in CLRB in Q3 2021 and held it in 6 quarters. The position peaked at $132K in Q3 2021. 19 funds tracked by Wall St. Rank hold CLRB as of Q1 2023.

  • Franklin Resources reported no remaining Cellectar Biosciences position as of Q1 2023 after selling out during the quarter.
  • Franklin Resources sold 345 Cellectar Biosciences shares in Q1 2023, an estimated $17.7K.
  • Franklin Resources first reported a position in Cellectar Biosciences in Q3 2021 and held it in 6 quarters.
  • Franklin Resources's Cellectar Biosciences position peaked at $132K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q1 2023.

Based on Franklin Resources's 13F filing for Q1 2023, filed 12 May 2023.